A Scalable Lysine Bioconjugation Platform: Reducing Development Burden as Clinical Demand Scales

3:30 pm - Wednesday 10th March 2027

  • Presenting quality-based driven development
  • Showcasing platform establishment
  • Leveraging multiple programme efficiency

Speakers:

Associate Director
AstraZeneca